Clinical trial
Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management
NCT04377321 is registered in ClinicalTrials.gov with Ministry of Health and Population, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management
- Lead sponsor
- Ministry of Health and Population, Egypt
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 10, 2019
- Completion date
- May 2, 2020
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
treatment adherence